BlackRock’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09B Buy
16,548,011
+152,888
+0.9% +$9.72M 0.02% 647
2025
Q4
$1.04B Buy
16,395,123
+869,376
+6% +$54.1M 0.02% 668
2025
Q3
$853M Sell
15,525,747
-152,120
-1% -$6.27M 0.02% 751
2025
Q2
$518M Buy
15,677,867
+114,089
+0.7% +$3.97M 0.01% 1030
2025
Q1
$626M Buy
15,563,778
+94,400
+0.6% +$4.34M 0.01% 887
2024
Q4
$728M Buy
15,469,378
+216,539
+1% +$11.2M 0.01% 823
2024
Q3
$805M Buy
15,252,839
+580,060
+4% +$32.3M 0.02% 753
2024
Q2
$795M Buy
14,672,779
+2,258,006
+18% +$136M 0.02% 705
2024
Q1
$870M Sell
12,414,773
-3,687,297
-23% -$285M 0.02% 673
2023
Q4
$1.34B Buy
16,102,070
+467,330
+3% +$16.9M 0.03% 460
2023
Q3
$461M Buy
15,634,740
+272,567
+2% +$9.08M 0.01% 957
2023
Q2
$501M Buy
15,362,173
+736,791
+5% +$27.3M 0.01% 938
2023
Q1
$515M Sell
14,625,382
-341,935
-2% -$13.9M 0.02% 897
2022
Q4
$686M Buy
14,967,317
+397,325
+3% +$17.1M 0.02% 692
2022
Q3
$706M Buy
14,569,992
+1,156,696
+9% +$55.7M 0.02% 637
2022
Q2
$527M Buy
13,413,296
+348,678
+3% +$14M 0.02% 809
2022
Q1
$481M Buy
13,064,618
+113,654
+0.9% +$4.04M 0.01% 1017
2021
Q4
$590M Sell
12,950,964
-311,983
-2% -$12M 0.02% 904
2021
Q3
$474M Buy
13,262,947
+1,608,545
+14% +$47.4M 0.01% 1019
2021
Q2
$231M Sell
11,654,402
-273,042
-2% -$6.41M 0.01% 1659
2021
Q1
$277M Buy
11,927,444
+316,365
+3% +$6.76M 0.01% 1476
2020
Q4
$241M Buy
11,611,079
+851,128
+8% +$15.6M 0.01% 1476
2020
Q3
$233M Buy
10,759,951
+1,398,262
+15% +$32.7M 0.01% 1271
2020
Q2
$221M Buy
9,361,689
+236,498
+3% +$4.43M 0.01% 1292
2020
Q1
$108M Sell
9,125,191
-435,411
-5% -$5.56M 0.01% 1594
2019
Q4
$101M Buy
9,560,602
+294,365
+3% +$3.02M ﹤0.01% 1952
2019
Q3
$105M Buy
9,266,237
+207,966
+2% +$2.61M ﹤0.01% 1867
2019
Q2
$102M Buy
9,058,271
+195,445
+2% +$1.88M ﹤0.01% 1897
2019
Q1
$71.7M Buy
8,862,826
+136,255
+2% +$1M ﹤0.01% 2078
2018
Q4
$55.2M Buy
8,726,571
+28,184
+0.3% +$207K ﹤0.01% 2181
2018
Q3
$85.7M Buy
8,698,387
+754,593
+9% +$6.05M ﹤0.01% 2060
2018
Q2
$65.9M Buy
7,943,794
+686,537
+9% +$5.71M ﹤0.01% 2202
2018
Q1
$52.3M Buy
7,257,257
+17,863
+0.2% +$153K ﹤0.01% 2239
2017
Q4
$59M Buy
7,239,394
+393,494
+6% +$4.47M ﹤0.01% 2182
2017
Q3
$99.3M Buy
6,845,900
+597,295
+10% +$8.16M 0.01% 1857
2017
Q2
$75.6M Buy
6,248,605
+3,206,723
+105% +$44.6M ﹤0.01% 1982
2017
Q1
$39.1M Buy
3,041,882
+3,038,630
+93,439% +$35.5M ﹤0.01% 2377
2016
Q4
$40K Buy
3,252
+211
+7% +$2.24K ﹤0.01% 3030
2016
Q3
$28K Buy
3,041
+414
+16% +$4.32K ﹤0.01% 3198
2016
Q2
$24K Buy
2,627
+582
+28% +$4.78K ﹤0.01% 3211
2016
Q1
$15K Sell
2,045
-342
-14% -$2.5K ﹤0.01% 2981
2015
Q4
$25K Sell
2,387
-1,300
-35% -$12.8K ﹤0.01% 2459
2015
Q3
$24K Buy
3,687
+2,900
+368% +$19.8K ﹤0.01% 2277
2015
Q2
$5K Sell
787
-563
-42% -$3.69K ﹤0.01% 3121
2015
Q1
$9K Hold
1,350
﹤0.01% 2778
2014
Q4
$11K Hold
1,350
﹤0.01% 2699
2014
Q3
$5K Buy
1,350
+459
+52% +$1.93K ﹤0.01% 3067
2014
Q2
$4K Hold
891
﹤0.01% 3138
2014
Q1
$8K Buy
891
+205
+30% +$1.85K ﹤0.01% 2851
2013
Q4
$4K Hold
686
﹤0.01% 3088
2013
Q3
$5K Buy
+686
New +$7.36K ﹤0.01% 2986

Other funds holding CYTK